2022 annual financial data
Intellia Therapeutics 2022 Operating income
Direct answer
Operating income was -458,164,000 USD.
Operating income was -458,164,000 USD and net income was -474,186,000 USD.
Operating cash flow was -333,287,000 USD.
Get free Intellia Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 52,121,000 USD
- Operating income
- -458,164,000 USD
- Net income
- -474,186,000 USD
- Operating cash flow
- -333,287,000 USD